# Keppra

NDC: 50474-002
Generic name: levetiracetam
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20060823

FDA application: NDA021872

## Active ingredients

- LEVETIRACETAM: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50474-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50474-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6d5784d-abf9-45fe-ac5a-d5c53bd50f7e
